Endonovo Therapeutics, Inc.
Endonovo Therapeutics, Inc. (ENDV) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · ENDV · as of Jun 9, 2026
Activity summary
Buy transactions
54
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
∞
Buy/Sell (by trades)
Overall sentiment
Endonovo Therapeutics, Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
ENDV insider buying and selling by quarter
ENDV insider selling · ENDV insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Recent insider transactions
ENDV executive sell shares · ENDV board member insider trading · ENDV insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jul 1, 2020 | Collier Alan Brian CEO | Purchase | 100 | $10 | Form 4 |
| Jul 1, 2020 | Collier Alan Brian CEO | Purchase | 100 | $10 | Form 4 |
| Jun 30, 2020 | Collier Alan Brian CEO | Purchase | 200 | $21 | Form 4 |
| Feb 22, 2020 | Collier Alan Brian Director | Purchase | 100 | $96 | Form 4 |
| Jan 2, 2020 | Collier Alan Brian Ceo | Purchase | 100 | $175 | Form 4 |
| Dec 30, 2019 | Collier Alan Brian Ceo | Purchase | 100 | $225 | Form 4 |
| Dec 20, 2019 | Collier Alan Brian Ceo | Purchase | 100 | $0 | Form 4 |
| Dec 16, 2019 | Collier Alan Brian Ceo | Purchase | 500 | $1 | Form 4 |
| Dec 12, 2019 | Collier Alan Brian Ceo | Purchase | 1,000 | $2 | Form 4 |
| Dec 11, 2019 | Collier Alan Brian Ceo | Purchase | 100 | $0 | Form 4 |
| Dec 11, 2019 | Collier Alan Brian Ceo | Purchase | 1,000 | $2 | Form 4 |
| Dec 10, 2019 | Collier Alan Brian Ceo | Purchase | 1,000 | $3 | Form 4 |
| Dec 10, 2019 | Collier Alan Brian Ceo | Purchase | 2,000 | $6 | Form 4 |
| Dec 5, 2019 | Collier Alan Brian Ceo | Purchase | 2,000 | $6 | Form 4 |
| Dec 4, 2019 | Collier Alan Brian Ceo | Purchase | 2,000 | $6 | Form 4 |
| Dec 4, 2019 | Collier Alan Brian Ceo | Purchase | 2,000 | $6 | Form 4 |
| Dec 2, 2019 | Collier Alan Brian Ceo | Purchase | 2,000 | $6 | Form 4 |
| Nov 29, 2019 | Collier Alan Brian Ceo | Purchase | 2,000 | $6 | Form 4 |
| Nov 27, 2019 | Collier Alan Brian Ceo | Purchase | 2,000 | $7 | Form 4 |
| Nov 27, 2019 | Collier Alan Brian Ceo | Purchase | 1,000 | $4 | Form 4 |
| Nov 25, 2019 | Collier Alan Brian Ceo | Purchase | 2,000 | $7 | Form 4 |
| Nov 22, 2019 | Collier Alan Brian Ceo | Purchase | 1,000 | $4 | Form 4 |
| Nov 22, 2019 | Collier Alan Brian Ceo | Purchase | 1,000 | $4 | Form 4 |
| Nov 20, 2019 | Collier Alan Brian Ceo | Purchase | 1,000 | $4 | Form 4 |
| Nov 4, 2019 | Collier Alan Brian CEO | Purchase | 10,000 | $58 | Form 4 |
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About ENDV insider trading
ENDV insider trades
Endonovo Therapeutics, Inc. (ENDV) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including ENDV. Over the past 12 months, 0 insiders have filed transactions with the SEC. ENDV insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Endonovo Therapeutics, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
ENDV insider trading · 5 questionsThe insiders of Endonovo Therapeutics, Inc. (ENDV) include executives and directors such as ENDV, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026